{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:13:10Z","timestamp":1791180790532,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T00:00:00Z","timestamp":1360713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00066-012-0275-0","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T14:20:14Z","timestamp":1360592414000},"page":"202-215","source":"Crossref","is-referenced-by-count":22,"title":["Cyclin D1, EGFR, and Akt\/mTOR pathway","Cyclin-D1-, EGFR- und Akt\/mTOR-Signalweg"],"prefix":"10.1007","volume":"189","author":[{"given":"D.","family":"Dionysopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pavlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kotoula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Karasmanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Angouridakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.T.","family":"Kalogeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"key":"275_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"Jemal","year":"2009","unstructured":"Jemal A et al (2009) Cancer statistics. CA Cancer J Clin 59:225\u2013249","journal-title":"CA Cancer J Clin"},{"key":"275_CR2","unstructured":"Ferlay J, Shin HR, Bray F et al (2010) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. http:\/\/globocan.iarc.fr. Accessed 07 January 2013"},{"key":"275_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00066-011-0041-8","volume":"188","author":"Duma","year":"2012","unstructured":"Duma MN, Kampfer S et al (2012) Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol 188:243\u2013247","journal-title":"Strahlenther Onkol"},{"key":"275_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-011-2262-2","volume":"187","author":"Rades","year":"2011","unstructured":"Rades D, Meyners T et al (2011) Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III\/IV squamous cell carcinoma of the head and neck. A matched-pair analysis. Strahlenther Onkol 187:541\u2013547","journal-title":"Strahlenther Onkol"},{"key":"275_CR5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","volume":"359","author":"Haddad","year":"2008","unstructured":"Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359:1143\u20131154","journal-title":"N Engl J Med"},{"key":"275_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00066-009-1967-y","volume":"185","author":"Olthoff","year":"2009","unstructured":"Olthoff A, Ewen A et al (2009) Organ function and quality of life after transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal cancer. Strahlenther Onkol 185:303\u2013309","journal-title":"Strahlenther Onkol"},{"key":"275_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00066-010-2178-2","volume":"187","author":"Semrau","year":"2011","unstructured":"Semrau S et al (2011) Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemo-radiotherapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. Strahlenther Onkol 187:15\u201322","journal-title":"Strahlenther Onkol"},{"key":"275_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00066-011-2217-7","volume":"187","author":"Selzer","year":"2011","unstructured":"Selzer E, Liederer S et al (2011) Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab. Strahlenther Onkol 187:373\u2013377","journal-title":"Strahlenther Onkol"},{"key":"275_CR9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00066-011-2275-x","volume":"187","author":"Maurer","year":"2011","unstructured":"Maurer J, Hipp M et al (2011) Dysphagia, Impact on quality of life after radio(chemo)therapy of head and neck cancer. Strahlenther Onkol 187:744\u2013749","journal-title":"Strahlenther Onkol"},{"key":"275_CR10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00066-011-1139-8","volume":"187","author":"Rades","year":"2011","unstructured":"Rades D, Seibold ND et al (2011) Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 187:626\u2013632","journal-title":"Strahlenther Onkol"},{"key":"275_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","volume":"277","author":"Mitsudomi","year":"2010","unstructured":"Mitsudomi T, Yatabe Y et al (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cencer. FEBS J 277:301\u2013308","journal-title":"FEBS J"},{"key":"275_CR12","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1158\/1078-0432.CCR-03-0249","volume":"10","author":"Amornphimoltham","year":"2004","unstructured":"Amornphimoltham P, Sriuranpong V et al (2004) Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10:4029\u20134037","journal-title":"Clin Cancer Res"},{"key":"275_CR13","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1158\/1078-0432.CCR-07-1041","volume":"13","author":"Molinolo","year":"2007","unstructured":"Molinolo AA, Hewitt SM et al (2007) Dissecting the Akt\/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 13:4964\u20134973","journal-title":"Clin Cancer Res"},{"key":"275_CR14","first-page":"175","volume":"2","author":"Bellacosa","year":"1996","unstructured":"Bellacosa A, Almadori G, Cavallo S et al (1996) Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2:175\u2013180","journal-title":"Clin Cancer Res"},{"key":"275_CR15","doi-asserted-by":"crossref","unstructured":"Skarlos P et al (2012) Cancer Chemother Pharmacol 69:533\u2013546","DOI":"10.1007\/s00280-011-1730-9"},{"key":"275_CR16","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23:9067\u20139072","journal-title":"J Clin Oncol"},{"key":"275_CR17","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","volume":"345","author":"Forastiere","year":"2001","unstructured":"Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head-and-neck cancer. N Engl J Med 345:1890\u20131900","journal-title":"N Engl J Med"},{"key":"275_CR18","first-page":"3058","volume":"9","author":"Ha","year":"2003","unstructured":"Ha PK et al (2003) A transcriptional progression model for head and neck cancer. Clin Cancer Res 9:3058\u20133064","journal-title":"Clin Cancer Res"},{"key":"275_CR19","first-page":"1179","volume":"63","author":"Freier","year":"2003","unstructured":"Freier K, Joos S et al (2003) Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63:1179\u20131182","journal-title":"Cancer Res"},{"key":"275_CR20","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1200\/JCO.2002.20.1.1","volume":"20","author":"Mendelsohn","year":"2002","unstructured":"Mendelsohn J (2002) Targeting the epidermal growth factor receptor for cancer therapy. J Clin Oncol 20(Suppl 18):1s\u201313s","journal-title":"J Clin Oncol"},{"key":"275_CR21","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1200\/JCO.1993.11.10.1873","volume":"11","author":"Dassonville","year":"1993","unstructured":"Dassonville O, Formento JL et al (1993) Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11:1873\u20131878","journal-title":"J Clin Oncol"},{"key":"275_CR22","first-page":"7350","volume":"62","author":"Ang","year":"2002","unstructured":"Ang KK, Berkey BA (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350\u20137356","journal-title":"Cancer Res"},{"key":"275_CR23","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/annonc\/mdr576","volume":"23","author":"Fountzilas","year":"2012","unstructured":"Fountzilas E, Markou K et al (2012) Identification and validation of gene expression models that predict clinical outcome in patients with early laryngeal cancer. Ann Oncol 23:2146\u20132153","journal-title":"Ann Oncol"},{"key":"275_CR24","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.1998.16.9.3069","volume":"16","author":"Pignataro","year":"1998","unstructured":"Pignataro L, Pruneri G, Carboni N et al (1998) Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol 16:3069\u20133077","journal-title":"J Clin Oncol"},{"key":"275_CR25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/00000478-200309000-00015","volume":"27","author":"Rhodes","year":"2003","unstructured":"Rhodes A (2003) Quality assurance in immunohistochemistry. Am J Surg Pathol 27:1284\u20131285","journal-title":"Am J Surg Pathol"},{"key":"275_CR26","doi-asserted-by":"crossref","unstructured":"Colombo N, McMeekin S et al (2007) A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer. J Clin Oncol. (ASCO Ann Meet Proc 25:18S (abstract 5516))","DOI":"10.1200\/jco.2007.25.18_suppl.5516"},{"key":"275_CR27","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1200\/JCO.2005.13.466","volume":"23","author":"Witzig","year":"2005","unstructured":"Witzig TE, Geyer SM et al (2005) Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. J Clin Oncol 23:5347\u20135356","journal-title":"J Clin Oncol"},{"key":"275_CR28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1023\/B:APPT.0000045781.46314.e2","volume":"9","author":"Aguirre","year":"2004","unstructured":"Aguirre D, Boya P et al (2004) Bcl-2 and CCND1\/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma. Apoptosis 9:797\u2013805","journal-title":"Apoptosis"},{"key":"275_CR29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.onc.1210715","volume":"27","author":"Averous","year":"2008","unstructured":"Averous J et al (2008) Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. Oncogene 27:1106\u20131113","journal-title":"Oncogene"},{"key":"275_CR30","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1158\/0008-5472.CAN-05-2994","volume":"66","author":"Kong","year":"2006","unstructured":"Kong A, Leboucher P, Leek R et al (2006) Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer. Cancer Res 66:2834\u20132843","journal-title":"Cancer Res"},{"key":"275_CR31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ejca.2005.03.018","volume":"41","author":"Dei","year":"2005","unstructured":"Dei Tos AP, EIlis I et al (2005) Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods? Eur J Cancer 41:1383\u20131392","journal-title":"Eur J Cancer"},{"key":"275_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.7-suppl_4-31","volume":"7","author":"Arteaga","year":"2002","unstructured":"Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7(Suppl 4):31\u201339","journal-title":"Oncologist"},{"key":"275_CR33","first-page":"4164","volume":"5","author":"Xia","year":"1999","unstructured":"Xia W, Lau YK et al (1999) Combination of EGFR, HER-2\/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5:4164\u20134174","journal-title":"Clin Cancer Res"},{"key":"275_CR34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/prca.200800001","volume":"3","author":"Espina","year":"2009","unstructured":"Espina V et al (2009) Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 3:874\u2013882","journal-title":"Proteomics Clin Appl"},{"key":"275_CR35","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/mcp.M700596-MCP200","volume":"7","author":"Espina","year":"2008","unstructured":"Espina V, Edmiston KH, Heiby M, Pierobon M et al (2008) A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 7:1998\u20132018","journal-title":"Mol Cell Proteomics"},{"key":"275_CR36","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2010.151233","volume":"56","author":"Hennig","year":"2010","unstructured":"Hennig G, Gehrmann M et al (2010) Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. Clin Chem 56:1845\u20131853","journal-title":"Clin Chem"},{"key":"275_CR37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/aps.2009.178","volume":"31","author":"Zhang","year":"2011","unstructured":"Zhang F, Wang ZM et al (2011) Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues. Acta Pharmacol Sin 31:111\u2013117","journal-title":"Acta Pharmacol Sin"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0275-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-012-0275-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0275-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T05:14:07Z","timestamp":1595394847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-012-0275-0"}},"subtitle":["Potential prognostic markers in localized laryngeal squamous cell carcinoma","Potenzielle Prognosemarker bei lokal begrenztem Plattenepithelzellkarzinom des Larynx"],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1007\/s00066-012-0275-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,13]]}}}